Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.
CONCLUSIONS: In acute pediatric manic or mixed episodes, early response to olanzapine at week 1 was strongly associated with ultimate response and remission at week 3, while absence of early response predicted the unlikely success of further treatment.
TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00050206.
PMID: 28922591 [PubMed - as supplied by publisher]
Source: Journal of Clinical Psychiatry - Category: Psychiatry Tags: J Clin Psychiatry Source Type: research
More News: Bipolar | Mania | Pediatrics | Psychiatry | Sleep Disorders | Sleep Medicine | Study | Zyprexa